The University of Louisville Foundation has made a “substantial” equity investment in PGXL, helping to fund the expansion of the lab’s human and technological infrastructures.

“Not only will the success of the company benefit thousands of patients, but it also will create new employment opportunities and economic impact,” according to Dr. James Ramsey, UL Foundation President.

Press release here.